The Impact of MDS-Related Genetic Mutations on Clinical Outcomes in Patients With NPM1-Mutated Acute Myeloid Leukemia

被引：0
|
作者：
Shahin, Omar [1 ]
Makoseh, Mohammad [1 ]
Abdelrahman, Zaid [1 ]
AlRabie, Kamal [1 ]
Khader, Renad [1 ]
Alyamani, Ahmad [2 ]
Dana, Waleed [1 ]
Marie, Lina [1 ]
机构：
[1] King Hussein Canc Ctr, Dept Med, Amman, Jordan
[2] King Hussein Canc Ctr, Dept Pharm, Amman, Jordan
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
AML; NPM1; MDS-related genetic mutations; STM;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-392
引用
收藏
页码：S312 / S312
页数：1
相关论文
共 50 条
  • [31] Clinicopathologic and genetic characterization of nonacute NPM1-mutated myeloid neoplasms
    Patel, Sanjay S.
    Ho, Caleb
    Ptashkin, Ryan N.
    Sadigh, Sam
    Bagg, Adam
    Geyer, Julia T.
    Xu, Mina L.
    Prebet, Thomas
    Mason, Emily F.
    Seegmiller, Adam C.
    Morgan, Elizabeth A.
    Steensma, David P.
    Winer, Eric S.
    Wong, Waihay J.
    Hasserjian, Robert P.
    Weinberg, Olga K.
    BLOOD ADVANCES, 2019, 3 (09) : 1540 - 1545
  • [32] TG-interacting factor 1 improves risk stratification in patients with NPM1-mutated acute myeloid leukemia
    Tang, Hongwei
    Zhang, Nan
    Li, Huan
    Chen, Ying
    Liu, Xinlei
    Xiao, Hongbo
    Deng, Jianchuan
    Zhou, Kang
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 32 (07): : 741 - 751
  • [33] Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1-Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients
    Bill, Marius
    Eckardt, Jan-Niklas
    Rausch, Christian
    Metzeler, Klaus H.
    Spiekermann, Karsten
    Stasik, Sebastian
    Sauer, Tim
    Scholl, Sebastian
    Hochhaus, Andreas
    Crysandt, Martina
    Bruemmendorf, Tim H.
    Krug, Utz
    Woermann, Bernhard
    Hiddemann, Wolfgang
    Goerlich, Dennis
    Sauerland, Maria Cristina
    Steffen, Bjoern
    Einsele, Hermann
    Neubauer, Andreas
    Burchert, Andreas
    Schaefer-Eckart, Kerstin
    Berdel, Wolfgang E.
    Schliemann, Christoph
    Krause, Stefan W.
    Hanel, Mathias
    Hanoun, Maher
    Kaufmann, Martin
    Fransecky, Lars
    Braess, Jan
    Ruhnke, Leo
    Schetelig, Johannes
    Middeke, Jan Moritz
    Serve, Hubert
    Baldus, Claudia D.
    Platzbecker, Uwe
    Mueller-Tidow, Carsten
    Bornhaeuser, Martin
    Herold, Tobias
    Thiede, Christian
    Roellig, Christoph
    BLOOD, 2023, 142
  • [34] Genetic biomarkers identify a subgroup of high-risk patients within low-risk NPM1-mutated acute myeloid leukemia
    Carbonell, Diego
    Suarez-Gonzalez, Julia
    Chicano, Maria
    Andres-Zayas, Cristina
    Diez-Diez, Miriam
    Rodriguez-Macias, Gabriela
    Muniz, Paula
    Kwon, Mi
    Anguita, Javier
    Diez-Martin, Jose Luis
    Buno, Ismael
    Martinez-Laperche, Carolina
    LEUKEMIA & LYMPHOMA, 2021, 62 (05) : 1178 - 1186
  • [35] Multi lineage dysplasia as assessed by immunophenotype has no impact on clinical-biological features and outcome of NPM1-mutated acute myeloid leukemia
    Mannelli, Francesco
    Ponziani, Vanessa
    Bonetti, Maria Ida
    Bencini, Sara
    Cutini, Ilaria
    Gianfaldoni, Giacomo
    Scappini, Barbara
    Pancani, Fabiana
    Rondelli, Tommaso
    Benelli, Matteo
    Caporale, Roberto
    Gelli, Anna Maria Grazia
    Peruzzi, Benedetta
    Longo, Giovanni
    Bosi, Alberto
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (10) : 869 - 879
  • [36] Acute Myeloid Leukemia with Erythroid Predominance: Are All Cases MDS-Related?
    Margolskee, Elizabeth
    Mikita, Geoffrey
    Oak, Jean
    Allen, M. B.
    Zuo, Zhuang
    Wang, Sa
    Arber, Daniel A.
    George, Tracy
    Hasserjian, Robert P.
    Orazi, Attilio
    LABORATORY INVESTIGATION, 2017, 97 : 362A - 362A
  • [37] Mutational spectrum of de novo NPM1-mutated acute myeloid leukemia patients older than 75 years
    Pettersson, Louise
    Holmgren, Benjamin
    Juliusson, Gunnar
    Lazarevic, Vladimir Lj
    Ehinger, Mats
    LEUKEMIA & LYMPHOMA, 2021, 62 (08) : 1958 - 1966
  • [38] Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML
    Cocciardi, Sibylle
    Saadati, Maral
    Weiss, Nina
    Spaeth, Daniela
    Kapp-Schwoerer, Silke
    Schneider, Isabelle
    Meid, Annika
    Gaidzik, Verena I.
    Skambraks, Sabrina
    Fiedler, Walter
    Kuehn, Michael W. M.
    Germing, Ulrich
    Mayer, Karin T.
    Luebbert, Michael
    Papaemmanuil, Elli
    Thol, Felicitas
    Heuser, Michael
    Ganser, Arnold
    Bullinger, Lars
    Benner, Axel
    Doehner, Hartmut
    Doehner, Konstanze
    HEMASPHERE, 2025, 9 (01):
  • [39] IMPACT OF EPIGENETIC MUTATIONS ON TREATMENT OUTCOMES AMONG DE NOVO NPM1-MUTATED AML
    Shatilova, A. A.
    Budaeva, I. G.
    Petukhov, A. V.
    Silonov, S. A.
    Lomaia, E. G.
    Nikulina, T. S.
    Mirolyubova, Yu. V.
    Alekseeva, Yu. A.
    Girshova, L. L.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S42 - S42
  • [40] Starry sky pattern predicts RAS pathway activation in NPM1-mutated acute myeloid leukemia
    Venanzi, Alessandra
    Cardinali, Valeria
    Perriello, Vincenzo
    Albano, Francesco
    Cimino, Gaetano
    Martino, Giovanni
    Marra, Andrea
    Sportoletti, Paolo
    Andresen, Vibeke
    Gjertsen, Bjorn T.
    Sica, Simona
    Chiusolo, Patrizia
    Martelli, Maria Paola
    Tiacci, Enrico
    Falini, Brunangelo
    AMERICAN JOURNAL OF HEMATOLOGY, 2025, 100 (01) : 139 - 143
12345